NCT06832592

Brief Summary

Bronchial cancer is a major oncological pathology, representing the leading cause of cancer death in France. Supportive oncological care (SOS) is defined as all the care and support necessary for patients throughout their journey, in addition to specific treatments. Despite their importance, their identification and accessibility remain heterogeneous in outpatient oncology. This single-center observational study aims to describe the supportive care needs of patients with bronchial cancer in the active phase of treatment at the Nord-Ouest Hospital in Villefranche-sur-Saône. A self-questionnaire based on the national SOS identification grid will be offered to 100 patients followed in thoracic oncology. The main objective is to identify priority needs perceived and expressed by patients, particularly in terms of psychological support, pain management, nutrition, physical activity, fatigue and social impact. Secondary objectives include the evaluation of the proposal and acceptance of SOS by patients, the analysis of the causes of refusal and the study of variations in needs according to the temporality of treatments and demographic characteristics. A descriptive statistical analysis will be carried out, supplemented by comparative tests to explore the relationships between identified needs and patient profiles. The expected results will make it possible to optimize the provision of supportive care in outpatient oncology, by proposing strategies adapted to the specific needs of patients with bronchial cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

February 10, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 18, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2025

Completed
Last Updated

April 8, 2025

Status Verified

February 1, 2025

Enrollment Period

2 months

First QC Date

February 7, 2025

Last Update Submit

April 4, 2025

Conditions

Keywords

Lung cancerSupportive oncological carePatient needsSelf-questionnaire

Outcome Measures

Primary Outcomes (1)

  • Proportion of Patients Reporting Unmet Supportive Care Needs Using a Standardized Identification Grid.

    Assessment of supportive care needs in patients with bronchial cancer using a standardized first-level identification grid. Needs will be categorized (e.g., psychological, nutritional, pain management, social support) and reported as the proportion of patients identifying at least one unmet need in each category.

    At the time of outpatient consultation (Day 0)

Secondary Outcomes (2)

  • Evaluate whether supportive care is offered by the healthcare team and accepted by patients.

    At the time of outpatient consultation (Day 0)

  • Analyze the causes of refusal of help by patients and evaluate the satisfaction of the supportive care offer

    At the time of outpatient consultation (Day 0)

Study Arms (1)

SOS-LUNG

population of 100 adults followed in the outpatient oncology department for lung cancer who are given a self-questionnaire on their need for supportive care after delivery of an information notice and collection of their non-opposition, over the period from February to April 2025.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient suffering from lung cancer and followed in the outpatient oncology department of the HNOV

You may qualify if:

  • Patient with bronchial cancer in the active phase of treatment followed in the Ambulatory Oncology department of HNO Villefranche sur Saône.
  • Major
  • Knowing how to read and write French
  • Affiliate to a Social Security scheme

You may not qualify if:

  • Patient with cognitive disorder(s)
  • Person under guardianship, curatorship or legal protection
  • Patient objecting to participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HNO Villefranche

Gleizé, 69400, France

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • ODIER LUC, Lung Doctor

    Hôpitaux Nord-Ouest Villefranche Sur Saône

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2025

First Posted

February 18, 2025

Study Start

February 10, 2025

Primary Completion

March 28, 2025

Study Completion

March 28, 2025

Last Updated

April 8, 2025

Record last verified: 2025-02

Locations